H. Sipma et al., THE PHOSPHOLIPASE-C ACTIVATING P-2U PURINOCEPTOR ALSO INHIBITS CYCLICAMP FORMATION IN DDT1 MF-2 SMOOTH-MUSCLE CELLS, European journal of pharmacology. Molecular pharmacology section, 268(3), 1994, pp. 431-437
The P-2U purinoceptor mediated effect on cellular cAMP was investigate
d in DDT1 MF-2 smooth muscle cells. Stimulation of these receptors by
ATP or UTP caused a pronounced decrease of about 50% in cellular cAMP
levels in forskolin or isoprenaline pretreated cells. This action of t
he nucleotides was concentration dependent with an IC50 of 9.4 +/- 0.2
mu M and 29.0 +/- 0.5 mu M for UTP and ATP, respectively and was inhi
bited by the P-2-purinoceptor antagonist suramin. The cAMP level appea
red to be modified by intracellular Ca2+, represented by an initial de
cline in cAMP. Neither inactivation of protein kinase C by staurospori
ne nor elevated cytoplasmic Ca2+ concentrations interfered with the su
stained decrease in cAMP levels induced by ATP or UTP, showing that th
is effect is not mediated via the phospholipase C pathway known to be
activated after P-2U purinoceptor stimulation in DDT1 MF-2 cells. Pert
ussis toxin inhibited the action of these nucleotides on the cellular
cAMP level. It can be concluded that the P-2U purinoceptor in DDT1 MF-
2 cells is coupled to different G-proteins, activating phospholipase C
and inhibiting adenylyl cyclase activity.